文献速递肺外科心外重症与机械循环支持

双肺移植中非计划术中ECMO撤除的安全性评估

Is Extracorporeal Membrane Oxygenation Withdrawal a Safe Option After Double-Lung Transplantation?
PubMed 文献 · Ann Thorac Surg · 2020-05-04

该单中心回顾性研究纳入2012至2018年436例双肺移植患者,排除桥接移植、多器官移植、再次移植及体外循环者,比较非计划术中ECMO组与无ECMO组及计划术中ECMO组的预后。结果显示非计划术中ECMO组1年和3年生存率低于无ECMO组,囊性纤维化病史是1年死亡的独立保护因素。

要点

  • 非计划术中ECMO患者1年和3年生存率低于无ECMO患者。
  • 囊性纤维化病史与1年死亡率降低独立相关。
  • 肺分配评分、术末3级肺移植物功能障碍及估计术中失血量是危险因素。

核心结论

  • 接受非计划术中ECMO的双肺移植患者预后较无需ECMO者差。
  • 预后差异可能源于初始病情严重程度、术中并发症导致ECMO植入的长期后果或撤机方案缺陷。

研究设计与样本

  • 回顾性单中心研究,2012至2018年436例双肺移植患者中排除桥接移植、多器官移植、研究期间再次移植及体外循环者。
  • 比较非计划术中ECMO组与无ECMO组及计划术中ECMO组。

主要发现

  • 样本中209例无需ECMO,77例接受非计划术中ECMO,14例接受计划术中ECMO。
  • 非计划术中ECMO组1年生存率低于无ECMO组(P = .043)。
  • 非计划术中ECMO组3年生存率低于无ECMO组(P = .032)。
  • 囊性纤维化病史是1年死亡率唯一的独立保护因素(P = .013)。
  • 肺分配评分(P = .001)、术末3级肺移植物功能障碍(P = .014)及估计术中失血量(P = .031)是危险因素。

临床怎么用

  • 双肺移植中应尽量限制ECMO的使用及持续时间。
  • 对非计划术中ECMO患者需关注初始病情严重程度及术中并发症。
  • 囊性纤维化病史可能提示1年预后较好。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is commonly used during double-lung transplantation. ECMO can be planned or unplanned, and used only during the procedure or extended postoperatively (intraoperative or extended). Our practice is to limit its use and duration as much as possible. We conducted this retrospective single-center study to assess prognoses of patients undergoing unplanned-intraoperative ECMO. METHODS: From among 436 patients who underwent double-lung transplantation from 2012 to 2018, we excluded those who underwent bridge-to-transplantation, multiorgan transplantation, repeated transplantation during the study period, and cardiopulmonary bypass. Unplanned-intraoperative ECMO group was compared with no-ECMO and planned-intraoperative ECMO groups. RESULTS: In our sample, 209 patients did not require ECMO, 77 underwent unplanned-intraoperative ECMO, and 14 underwent planned-intraoperative ECMO. One-year and 3-year survival were lower in unplanned-intraoperative ECMO group than in the no-ECMO group (P = .043 and P = .032, respectively). The only independent protective factor related to 1-year mortality was history of cystic fibrosis (P = .013). Lung allocation score (P = .001), grade 3 pulmonary graft dysfunction at end-surgery status (P = .014), and estimated intraoperative blood loss (P = .031) were risk factors. CONCLUSIONS: Patients who underwent unplanned-intraoperative ECMO showed poorer prognoses than patients who did not require ECMO. This finding may be explained by differences in initial condition severity, by long-term consequences of the intraoperative complications leading to ECMO pump implantation, or by flaws in our weaning protocol.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Fessler J, Sage E, Roux A, et al. Is Extracorporeal Membrane Oxygenation Withdrawal a Safe Option After Double-Lung Transplantation? Ann Thorac Surg. 2020. PMID: 32380057. doi:10.1016/j.athoracsur.2020.03.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。